Non invasive neuromodulation device for Parkinson Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Michigan, Ann Arbor, MI
Parkinson Disease
Non invasive neuromodulation device - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study investigates whether vestibular (inner ear) dysfunction is a cause for poor balance in Parkinson Disease (PD), and whether inner ear stimulation with a small device may improve balance. This study will involve clinical testing, brain imaging, and an interventional treatment device for symptoms.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Parkinson Disease

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: after a week of treatment

after a week of treatment
Freezing of Gait

Trial Safety

Safety Progress

1 of 3

Other trials for Parkinson Disease

Trial Design

2 Treatment Groups

Active Intervention
1 of 2
Sham Intervention
1 of 2
Experimental Treatment
Non-Treatment Group

64 Total Participants · 2 Treatment Groups

Primary Treatment: Non invasive neuromodulation device · Has Placebo Group · N/A

Active Intervention
Device
Experimental Group · 1 Intervention: Non invasive neuromodulation device · Intervention Types: Device
Sham Intervention
Device
ShamComparator Group · 1 Intervention: Non invasive neuromodulation device (sham) · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: after a week of treatment
Closest Location: University of Michigan · Ann Arbor, MI
Photo of university of michigan comprehensive cancer center 1Photo of university of michigan comprehensive cancer center 2Photo of university of michigan comprehensive cancer center 3
2022First Recorded Clinical Trial
17 TrialsResearching Parkinson Disease
1005 CompletedClinical Trials

Who is running the clinical trial?

University of MichiganLead Sponsor
1,597 Previous Clinical Trials
6,328,993 Total Patients Enrolled
19 Trials studying Parkinson Disease
1,414 Patients Enrolled for Parkinson Disease
US Department of Veterans AffairsFED
853 Previous Clinical Trials
470,746 Total Patients Enrolled
14 Trials studying Parkinson Disease
926 Patients Enrolled for Parkinson Disease

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.